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Conclusions: ABSI couldn’t predict the new onset of hypertension in Chinese adult
population from Chengdu community during 15-years follow up, while BMI/ WC
could.
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Investigation of the prevalence of obstructive sleep apnea hypopnea syndrome
and cardiovascular disease in the population of Navy veteran who is older
than or equal to 60 years old
Yin Zhong, Yang Ye
Department of Cardiology, Navy General Hospital
Objectives: To investigate the prevalence of obstructive sleep apnea hypopnea syn-
drome (0SAS) and cardiovascular disease in the population of Navy veteran who is
older than or equal to 60 years old.
Methods: There are 1961 Navy veteran who is older than or equal to 60 years old
were inrolled. Everyone ﬁnished the standardized questionnaire. Polysomnography
(PSG), ordinary and/or dynamic electrocardiogram, blood pressure and coronary
angiography was performed for each one.
Results: In all 1961 people, 531 (27.1%) people have OSAS, 366 (18.7%) people with
coronary heart disease (CHD), 67 (3.4%) people with chronic heart failure (CHF), 323
(16.5%) people with diabetes. Of 531 OSAS patients, 235 (44.3%) patients with CHD,
322 (60.66%) complicated with hypertension, 271 (51.04%) had arrhythmia, 36
(6.8%) patients with CHF, 228 (42.9%%) patients with diabetes. At the same time,
among 1430 non-OSAS people, 131 (9.2%) people with CHD, 31 (2.2%) people with
CHF, 95 (6.6%) people with diabetes. At the same time, our data show that obese, high
BMI (kg/m2) and neck circumference (CM) were risk factors for OSAS, and the risk
of cardiovascular of cardiovascular disease increased with the severity of OSAS.
Conclusions: The prevalence of OSAS and cardiovascular disease were signiﬁcantly
increased among Navy veteran who is older than or equal to 60 years old. The
prevalence of cardiovascular disease in patients with OSAS was signiﬁcantly higher
than that of non-OSAS people. And prove that obese, high BMI (kg/m2) and neck
circumference (CM) were risk factors for OSAS, and the risk of cardiovascular of
cardiovascular disease increased with the severity of OSAS.
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Renal function decline has a different effect on predicting CVD risk in various
populations- a Chinese longitudinal study
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Objectives: Chronic kidney disease (CKD) is generally considered an independent
risk factor for cardiovascular disease (CVD) development, but rates in individuals
with estimated glomerular ﬁltration rate (eGFR)>60 ml/min/1.73 m2 are uncertain.
The purpose of this study was to examine the association exists between eGFR and
Framingham global CVD risk score (FRS) in a Chinese population with no CKD or
CVD.
Methods: A total of 333 participants were divided into three groups based on
FRS. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
and CKD-EPI equation for Asians (CKD-EPI-ASIA) were used to measure eGFR.
Results: A signiﬁcant inverse association between eGFR and FRS was conﬁrmed with
Pearson correlation coefﬁcients of -0.669, -0.698 (eGFRCKD-EPI, P<0.01) and -0.658,
-0.690 (eGFRCKD-EPI-ASIA, P<0.01). This association gradually diminished with
progression from the low- to high-risk groups (eGFRCKD-EPI, r¼-0.615, -0.282,
-0.197, P<0.01, P<0.01, P>0.05; similar results according to the CKD-EPI-ASIA
equation). In the low- or moderate-risk new-groups, this association became stronger
with increased FRS (eGFRCKD-EPI-ASIA, r¼-0557, -0.622 or -0.326, -0.329, P<0.01).
In contrast to the results from 2008, eGFR was independently associated with FRS
following adjustment for traditional cardiovascular risk factors (P<0.05).
Conclusions: Renal function has a different effect on predicting CVD risk in various
populations. With increasing FRS and decreasing eGFR, it is also independently
associated with CVD, even in individuals with eGFR>60 ml/min/1.73 m2.
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Prevention of Cardiovascular Disease in HIV-Infected Patients
Ning Jiang, Myat Soe, Linda Green
Prince George’s Hospital Center
Objectives: World Health Organization (WHO) estimates that cardiovascular disease
(CVD) and human immunodeﬁciency virus (HIV) will top the causes for global mor-
tality and disability in 2030. How to develop and implement effective primary pre-
vention strategy in HIV-infected patients with high cardiovascular risk is of paramount
importance. We conduct this retrospective study to assess cardiovascular risk and
implement prophylactic strategy as well as aspirin use in patients with HIV infection.
Methods: Federally-funded Ryan White program helps coordinate comprehensive
medical care for uninsured HIV-infected patients. The medical records of 115
consecutive HIV-infected adults (>18 years old) from January to December 2012
were reviewed. Multiple variables of socio-demographic characteristics, laboratory
ﬁndings and treatment were collected. Framingham risk score (FRS) was calculated to
assess 10-year cardiovascular risk, and D:A:D score based on traditionalJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Ecardiovascular risk factors as well as HIV-speciﬁc factors was calculated to assess 5-
year cardiovascular risk.
Results: A total of 115 HIV-infected individuals (mean age: 44.5 years) were included
in this cross-sectional study. In federally funded Ryan White program, the prevalence
of cardiovascular risk factors were markedly higher than those in D:A:D study,
notably hypertension (32.2 vs 7.2), obesity (23.8 vs 4.8), and diabetes (9.6 vs 2.8).
The proportion of HIV-infected patients with low, intermediate and high cardiovas-
cular risk were 65.2%, 20.0% and 14.8% using FRS, while 44.3%, 47.0% and 8.7%
using D:A:D prediction. Further analysis showed that FRS, D:A:D and stroke risk
score correlated well. Even if we implement appropriate approach ensuring that no
progression of the underlying risk factors, patients with high cardiovascular risk are
estimated to be doubled in the next 10 years. After screening with the United States
Prevention Services Task Force (USPSTF) recommended criteria, 57 patients (52.8%)
should be on aspirin for primary prevention of CVD. However, only 9.3% of the
patients use aspirin as primary prevention of CVD.
Conclusions: In this newly insured HIV/AIDS population, cardiovascular risk is
consistently high estimated for various diseases in different time horizons which might
reﬂect the high prevalence of risk factors. An effective intervention strategy to reduce
CVD burden requires more active identiﬁcation and more aggressive management of
traditional and HIV-speciﬁc cardiovascular risks.
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Outdoor air pollution and hospital emergency room visit for stroke in a Chinese
southern city
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Objectives: We investigated the relationship between daily changes in atmospheric
pollutants and hospital emergency room visit (ERV) for stroke.
Methods: Data of daily hospital ERV for stroke and atmospheric pollutants in
Changsha city between 2008 and 2009 were collected. Using a time-stratiﬁed case-
crossover design we built generalized linear Poisson models to analyze association
between atmospheric pollutant and stroke incidence in cold season (December-April)
and warm season (May-November).
Results: We found sulfur dioxide was signiﬁcantly associated with TIA (P<0.05) in
lags of 0, 1, 3 days in cold seasons. A 10mg/m3 increase of PM10 was signiﬁcantly
associated with ERV for cerebra hemorrhage (OR, 1.466; 95% CI, 1.139-1.887) in lag
1 day in cold season. Atmospheric pollutants were not associated with ERV for ce-
rebral infarction (P>0.05).
Conclusions: This study demonstrates Changes of atmospheric sulfur dioxide levels
in Changsha is signiﬁcantly associated with stroke incidence in cold seasons.Prevention of Cardiovascular DiseaseGW25-e2337
Prevalence of risk factors and performance of evidence-based medicine among
hospitalized patients with acute coronary syndromes - Results from the Bridging
the Gap on CHD Secondary Prevention in China (BRIG) project
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Objectives: To analyze the distribution of multiple risk factors for hospitalized pa-
tients with acute coronary syndromes (ACS) and explore the status and determinants
of evidence-based performance.
Methods: This was a multi-center cross-sectional study based on 34 hospitals from
22 provinces of China. From each hospital, more than 90 ACS patients were
consecutively enrolled since April 15, 2012 according to a standard protocol. A
total of 3253 patients with complete data were eligible for the ﬁnal analysis in this
study.
Results: (1) The mean age of male patients with ACS was lower than that of female
patients (60.4 years vs 66.2 years, P<0.01). Nearly 60% of ACS patients were under
65-years old. Early onset of ACS accounted for a quarter of male patients (< 55
years of age) and two-thirds of female patients (< 65 years old). (2) Of four ACS
major risk factors including hypertension, hyperlipidemia, smoking and diabetes,
more than 90% of ACS patients had one or more risk factors and of those about two-
thirds of patients had two or more risk factors. The prevalence of hypertension was
the highest (68.4%), followed by smoking rate in males (42.7%), or hyperlipidemia
rate in females (44.5%). (3) The proportion of PCI treatment was higher in male
patients than female patients (57.5% vs 42.0%, P<0.01). As for the application of
evidence-based drugs, 95.3% of ACS patients took aspirin, which is the most
commonly used drug. The second was statin (90.1%). The lowest was ACEI or ARBpidemiology, Prevention and Control C103
